Presence of bronchoalveolar lavage fluid necessary for platelet activating factor-induced ciliary depression. 1994

Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
Department of Otolaryngology, Osaka City University Medical School, Japan.

Many different mediators have been implicated in allergic responses and allergic diseases of the respiratory tract. The influence of several allergic inflammatory mediators on the ciliary activity has been well studied. However, ciliary responsiveness to platelet-activating factor (PAF) is yet to be established conclusively. Our study concerns the response of normal tracheal cilia from the guinea pig during an in vitro contact with PAF. PAF at concentrations between 10(-10) and 10(-8) M never affected the ciliary activity. On the other hand, such concentrations of PAF inhibited the ciliary activity in a dose-response fashion within 5 min in the presence of alveolar macrophages. Such a ciliary dysfunction should allow allergens and other molecules to easily invade epithelium and submucosa of the airway, resulting in an increased epithelial permeability which might be a mild manifestation of airway hyperresponsiveness and make a significant contribution to further airway hyperresponsiveness.

UI MeSH Term Description Entries
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002923 Cilia Populations of thin, motile processes found covering the surface of ciliates (CILIOPHORA) or the free surface of the cells making up ciliated EPITHELIUM. Each cilium arises from a basic granule in the superficial layer of CYTOPLASM. The movement of cilia propels ciliates through the liquid in which they live. The movement of cilia on a ciliated epithelium serves to propel a surface layer of mucus or fluid. (King & Stansfield, A Dictionary of Genetics, 4th ed) Motile Cilia,Motile Cilium,Nodal Cilia,Nodal Cilium,Primary Cilia,Primary Cilium,Cilium,Cilia, Motile,Cilia, Nodal,Cilia, Primary,Cilium, Motile,Cilium, Nodal,Cilium, Primary
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014132 Trachea The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi. Tracheas
D016676 Macrophages, Alveolar Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells. Alveolar Macrophages,Macrophages, Pulmonary,Pulmonary Macrophages,Macrophage, Pulmonary,Pulmonary Macrophage,Alveolar Macrophage,Macrophage, Alveolar

Related Publications

Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
April 1990, The European respiratory journal,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
July 1992, Clinical and experimental pharmacology & physiology,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
March 1993, Nihon Kyobu Shikkan Gakkai zasshi,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
July 1997, American journal of respiratory and critical care medicine,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
August 1992, The American review of respiratory disease,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
December 1991, Lipids,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
January 1999, Life sciences,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
March 2005, Annals of the rheumatic diseases,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
July 2005, Journal of thrombosis and haemostasis : JTH,
Y Ohashi, and Y Ohno, and Y Sugiura, and H Okamoto, and A Tanaka, and Y Kakinoki, and H Sakamoto, and M Hayashi, and Y Nakai
November 2002, Thrombosis research,
Copied contents to your clipboard!